Physician profile
Sean M Gratton
NPI 1952535353
$1,417.22
in general payments reported to CMS, 2019-2025
15 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Neuro-Ophthalmology provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $17.71 · 2021: $314 · 2022: $328 · 2023: $251 · 2024: $148 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $391.43 | 2021-2025 | |
| Biogen, INC. | $298.34 | 2019-2025 | Vumerity |
| Tg Therapeutics, INC. | $125.00 | 2024 | |
| Acadia Pharmaceuticals INC | $123.98 | 2021 | |
| Novartis Pharmaceuticals Corporation | $112.40 | 2019-2021 | |
| Grt US Holding, INC. | $94.10 | 2022 | |
| Emd Serono, INC. | $74.66 | 2023 | |
| Horizon Therapeutics Plc | $60.32 | 2021 | |
| Sun Pharmaceutical Industries INC. | $35.38 | 2023-2025 | Cequa |
| Apellis Pharmaceuticals, INC. | $22.50 | 2024 | Syfovre |
| Mallinckrodt Hospital Products INC. | $20.57 | 2023 | Acthar |
| Sunovion Pharmaceuticals INC. | $17.71 | 2020 | |
| Allergan, INC. | $16.21 | 2019 | |
| Boston Scientific Corporation | $12.57 | 2022 | |
| Abbvie INC. | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Gratton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.